| Expression pattern: |
UP |
| Associated gene: |
YTHDF2 |
| Associated microRNA: |
- |
| Biological function: |
promotes glioblastoma tumorigenesis and stem cell malignancy by activating MET signaling |
| Molecular mechanism: |
circMET is an m6A-modified coding circRNA; YTHDF2 facilitates its translation into MET404, which activates MET signaling independent of HGF |
| Biological pathway or process: |
ceRNA regulation (not specified); other pathway/process (promotes) |
| Detected method: |
Q
B
S
|
| Validation methods: |
Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Northern Blot; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RNA-seq; Bioinformatics Analysis; MeRIP / MeRIP-seq; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry); IF (Immunofluorescence); Western Blot; ELISA; Co-IP; RNA Pull-Down |
| Clinical significance: |
High MET404 expression predicted worse overall survival of GBM patients |
| Description: |
This study identifies circMET as an m6A-modified circular RNA from the MET gene that is highly expressed in GBM/GSCs. circMET interacts with the m6A reader YTHDF2 to facilitate translation of the MET404 protein, which drives GBM tumorigenesis by constitutively activating MET signaling independent of HGF. |
| Confidence score: |
0.8886 |